Guru Ownership Trend
Guru Analysis for BridgeBio Pharma, Inc. (BBIO)
BridgeBio Pharma, Inc. (BBIO), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q2 2026, a total of 10 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $949.27 M.
Top institutional holders include Andreas Halvorsen and Steven Cohen.
Institutional sentiment is currently Bullish. This is evidenced by a $33.29 M net inflow during the quarter.
Recent activity highlights Renaissance Technologies (RenTech) who increased their stake by 134.3%. Conversely, Andreas Halvorsen reduced exposure by 16.0%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q2 2026)
Guru Consensus (Q2 2026)
FAQs for BridgeBio Pharma, Inc. (BBIO)
Major holders include Andreas Halvorsen ($741.02 M), Steven Cohen ($113.64 M), Renaissance Technologies (RenTech) ($63.82 M). According to the latest reported data, 10 tracked investment managers collectively hold approximately 13.74 M shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $33.29 M, with 7 managers increasing positions and 3 managers reducing holdings.
During the most recent reporting period, 3 managers trimmed their positions, while 0 fully exited BBIO. The total reported sell value was $142.55 M.
Yes, 3 managers opened new positions in BBIO, and 4 increased their existing holdings. The total reported buy value was $175.84 M.
